The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome

Journal of Pathology

Volumn 204, Issue 5, 2004, Pages 605-612

  Hirata, Hitoshi ^a   Nagakura, Takeshi ^a   Tsujii, Masaya ^a   Morita, Akimasa ^b   Fujisawa, Kohzo ^b   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY   (Japan)

^b Suzuka Kaisei General Hospital   (Japan)

Author keywords

Angiogenesis; Atherosclerosis; Carpal tunnel syndrome; Prostaglandin; Repetitive trauma injury; Tenosynovium; Vascular endothelial growth factor

Indexed keywords

COLLAGEN TYPE 3; CYCLINE; PROSTAGLANDIN E2; VASCULOTROPIN; COLLAGEN; VASCULOTROPIN A;

ADULT; AGED; ANAMNESIS; ANGIOGENESIS; ARTERIOLE; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY; CARPAL TUNNEL SYNDROME; CELL PROLIFERATION; CELL REGENERATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EDEMA; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STATISTICAL ANALYSIS; SYNOVIUM; TISSUE DEGENERATION; VASCULAR SMOOTH MUSCLE; CELL DIVISION; DISEASE COURSE; IMMUNOLOGY; MECHANICAL STRESS; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TENDON; VASCULARIZATION;

ADULT; AGED; CARPAL TUNNEL SYNDROME; CELL DIVISION; COLLAGEN; DINOPROSTONE; DISEASE PROGRESSION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; STRESS, MECHANICAL; SYNOVIAL MEMBRANE; TENDONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 9744249499     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1673     Document Type: Article

References (31)

1. Scelsi R, Zanlungo M, Tenti P. Carpal tunnel syndrome: anatomical and clinical correlations and morphological and ultrastructural aspects of the tenosynovial sheath. Ital J Orthop Traumatol 1989; 15(1): 75-80.
2. Neal NC, MeManners J, Stirling GA. Pathology of the flexor tendon sheath in the spontaneous carpal tunnel syndrome. J Hand Surg [Br] 1987; 12(2): 229-232.
3. Sabo RM. Carpal tunnel syndrome: general. In Operative Nerve Repair and Reconstruction, Gelberman RH (ed). Lippincott: Philadelphia, 1991; 939-948.
4. Padua L, Padua R, Aprile I, D'Amico P, Tonali P. Carpal tunnel syndrome: relationship between clinical and patient-oriented assessment. Clin Orthop Related Res 2002; 395: 128-134.
5. Paavonen K, Mandelin J, Partanen T, et al. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol 2002; 29(1): 39-45.
6. Miotla J, Maciewicz R, Kendrew J, Feldmann M, Paleolog E. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 2000; 80(8): 1195-1205.
7. Afuwape AO, Feldmann M, Paleolog EM. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Gene Ther 2003; 10(23): 1950-1960.
8. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res 2002; 4(Suppl 3): S81-90.
9. Banes AJ, Gilbert J, Taylor D, Monbureau O. A new vacuum-operated stress-providing instrument that applies static or variable duration cyclic tension or compression to cells in vitro. J Cell Sci 1985; 75: 35-42.
10. Brown RA, Weiss JB, Tomlinson IW, Phillips P, Kumar S. Angiogenic factor from synovial fluid resembling that from tumours. Lancet 1980; 1(8170): 682-685.
11. Sattar A, Kumar P, Kumar S. Rheumatoid- and osteo-arthritis: quantitation of ultrastructural features of capillary endothelial cells. J Pathol 1986; 148(1): 45-53.
12. Semble EL, Turner RA, McCrickard EL. Rheumatoid arthritis and osteoarthritis synovial fluid effects on primary human endothelial cell cultures. J Rheumatol 1985; 12(2): 237-241.
13. Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. J Rheumatol 1997; 24(7): 1253-1259.
14. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13(1): 18-32.
15. Inoue H, Takamori M, Nagata N, et al. An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis. Inflamm Res 2001; 50(2): 65-72.
16. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4 2): 197-250.
17. Inoue H, Takamori M, Shimoyama Y, Ishibashi H, Yamamoto S, Koshihara Y. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. Br J Pharmacol 2002; 136 2): 287-295.
18. Freeland AE, Tucci MA, Barbieri RA, Angel MF, Nick TG. Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndrome. Microsurgery 2002; 22(8): 378-385.
19. Talmor M, Patel MP, Spann MD, et al. COX-2 up-regulation in idiopathic carpal tunnel syndrome: Plast Reconstr Surg 2003; 112(7): 1807-1814.
20. Tucci MA, Barbieri RA, Freeland AE. Biochemical and histological analysis of the flexor tenosynovium in patients with carpal tunnel syndrome. Biomed Sci Instrum 1997; 33: 246-251.
21. Giatromanolaki A, Sivridis E, Athanassou N, et al. The angiogenic pathway 'vascular endothelial growth factor/flk-1(KDR)-receptor' in rheumatoid arthritis and osteoarthritis. J Pathol 2001; 194(1): 101-108.
22. Paavonen K, Mandelin J, Partanen T, et al. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol 2002; 29(1): 39-45.
23. Ritchlin C. Fibroblast biology: effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2000; 2 5): 356-360.
24. Fu SC, Wang W, Pau HM, Wong YP, Chan KM, Rolf CG. Increased expression of transforming growth factor-beta1 in patellar tendinosis. Clin Ortho 2002; July(400): 174-183.
25. Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med 1999; 27(6): 393-408.
26. Khan KM, Cook JL, Kannus P, Maffulli N, Bonar SF. Time to abandon the 'tendinitis' myth. Br Med J 2002; 324(7338): 626-627.
27. Yu JS, Popp JE, Kaeding CC, Lucas J. Correlation of MR imaging and pathologic findings in athletes undergoing surgery for chronic patellar tendinitis. Am J Roentgenol 1995; 165(1): 115-118.
28. Alfredson H, Lorentzon M, Backman S, Backman A, Lerner UH. cDNA-arrays and real-time quantitative PCR techniques in the investigation of chronic Achilles tendinosis. J Orthop Res 2003; 21(6): 970-975.
29. Messner K, Wei Y, Andersson B, Gillquist J, Rasanen T. Rat model of Achilles tendon disorder: a pilot study. Cells Tissues Organs 1999; 165(1): 30-39.
30. Riley GP, Curry V, DeGroot J, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol 2002; 21(2): 185-195.
31. Jarvinen M, Jozsa L, Kannus P, Jarvinen TL, Kvist M, Leadbetter W. Histopathological findings in chronic tendon disorders. Scand J Med Sci Sports 1997; 7(2): 86-95.